Zobrazeno 1 - 10
of 240
pro vyhledávání: '"Schorzman AN"'
Publikováno v:
International Journal of Nanomedicine, Vol 2014, Iss Issue 1, Pp 3601-3610 (2014)
Lei Peng,1 Allison N Schorzman,2 Ping Ma,1 Andrew J Madden,2 William C Zamboni,2–4 Soumya Rahima Benhabbour,1 Russell J Mumper1,4 1Center for Nanotechnology in Drug Delivery, Division of Molecular Pharmaceutics, UNC Eshelman School of Pharmacy, Uni
Externí odkaz:
https://doaj.org/article/8071f753f3c24c3bad81a94c0084f4b1
Autor:
Roach, Matthew K., Wirz, Phillip, Rouse, Jeremy, Schorzman, Allison, Beard, Clayton W., Scott, David
Publikováno v:
In Molecular Therapy - Methods & Clinical Development 12 September 2024 32(3)
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Antibodies, Vol 10, Iss 3, p 30 (2021)
Antibody-drug conjugates (ADCs) appear to be in a developmental boom, with five FDA approvals in the last two years and a projected market value of over $4 billion by 2024. Major advancements in the engineering of these novel cytotoxic drug carriers
Externí odkaz:
https://doaj.org/article/86bf972f21754c5aacaf27bbb3da639c
Autor:
Byrne, James D., Jajja, Mohammad R. N., Schorzman, Allison N., Keeler, Amanda W., Luft, J. Christopher, Zamboni, William C., DeSimone, Joseph M., Yeh, Jen Jen
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America, 2016 Feb . 113(8), 2200-2205.
Externí odkaz:
https://www.jstor.org/stable/26467830
Autor:
Alka Prasher, Roopali Shrivastava, Denali Dahl, Preetika Sharma-Huynh, Panita Maturavongsadit, Tiffany Pridgen, Allison Schorzman, William Zamboni, Jisun Ban, Anthony Blikslager, Evan S. Dellon, Soumya Rahima Benhabbour
Publikováno v:
Polymers, Vol 13, Iss 4, p 557 (2021)
Eosinophilic esophagitis (EoE) is a chronic atopic disease that has become increasingly prevalent over the past 20 years. A first-line pharmacologic option is topical/swallowed corticosteroids, but these are adapted from asthma preparations such as f
Externí odkaz:
https://doaj.org/article/6b78785d1e1f4d1ebbae2b7bb6374f4c
Autor:
Andrew T. Lucas, Ryan Robinson, Allison N. Schorzman, Joseph A. Piscitelli, Juan F. Razo, William C. Zamboni
Publikováno v:
Antibodies, Vol 8, Iss 1, p 3 (2019)
The rapid advancement in the development of therapeutic proteins, including monoclonal antibodies (mAbs) and antibody-drug conjugates (ADCs), has created a novel mechanism to selectively deliver highly potent cytotoxic agents in the treatment of canc
Externí odkaz:
https://doaj.org/article/9a6f5e6f80ac4da8837653e210995036
Autor:
Chu, Kevin S., Schorzman, Allison N., Finniss, Mathew C., Bowerman, Charles J., Peng, Lei, Luft, James C., Madden, Andrew J., Wang, Andrew Z., Zamboni, William C., DeSimone, Joseph M.
Publikováno v:
In Biomaterials November 2013 34(33):8424-8429
Autor:
Kristy M. Ainslie, William C. Zamboni, Allison N. Schorzman, Kathryn M. Moore, Taek Lee, Elizabeth G. Graham-Gurysh, Eric M. Bachelder, Shawn Hingtgen
Publikováno v:
ACS Applied Materials & Interfaces. 12:19345-19356
Current interstitial therapies for glioblastoma can overcome the blood-brain barrier but fail to optimally release therapy at a rate that stalls cancer reoccurrence. To address this lapse, acetalated dextran (Ace-DEX) nanofibrous scaffolds were used
Autor:
Andrew T. Lucas, Lauren S. L. Price, Allison N. Schorzman, Mallory Storrie, Joseph A. Piscitelli, Juan Razo, William C. Zamboni
Publikováno v:
Antibodies, Vol 7, Iss 1, p 10 (2018)
Major advances in therapeutic proteins, including antibody–drug conjugates (ADCs), have created revolutionary drug delivery systems in cancer over the past decade. While these immunoconjugate agents provide several advantages compared to their smal
Externí odkaz:
https://doaj.org/article/7d650a79f5314a98a635b976f287e44e